NEWS: Curebase closes $40M Series B with strategic investment by Gilead. Read about it in TechCrunch, Fierce Biotech, andEndpoints News.
lorem ipsum
Get the case study
Blue Note Therapeutics was looking to recruit close to 400 patients in a fully-remote randomized controlled trial investigating a prescription digital therapeutic to treat anxiety and depression in oncology patients.